Web update: Incidence of selected cancers in 2006–2010 - Web update - Overview

Web update: Incidence of selected cancers in 2006–2010

Overview

Cancer is a major cause of illness in Australia and has a substantial social and economic impact on individuals, families and the community.

Local information about cancer incidence – newly diagnosed cases of cancer – offers important context for local health care professionals.

Cancer incidence rates are provided for all cancers combined as well as breast, cervical, prostate, colorectal, lung and melanoma of the skin. Cancers were selected based on their importance to public health care providers because they are the most commonly diagnosed, have modifiable risk factors or have a population-based screening program.

All rates are age-standardised, and are presented for the 31 Primary Health Network (PHN) areas and more than 300 smaller local areas across Australia. Data are available for the five-year period from 2006 to 2010, as at the time of creation, 2010 was the most recent year for which actual data was available nationally.

The data show that:

  • Nationally, the incidence of all cancers was 498 new cases per 100,000 people (age-standardised)
  • Across PHN areas, rates ranged from 452 (Northern Territory) to 555 new cases per 100,000 people (Western Queensland)
  • For cervical and lung cancers and melanoma of the skin, the PHN area with the highest incidence rate (age-standardised) was more than twice that of the PHN area with the lowest rate
  • There was even greater variation in incidence rates across the smaller local areas.

Infographic text

In 2006–2010, the incidence of all cancers rate ranged across Primary Health Network areas:

  • The national rate was 498 cases per 100,000 people (age-standardised)
  • The rate in Western Queensland was 555 cases per 100,000 people (age-standardised)
  • The rate in Northern Territory was 452 cases per 100,000 people (age-standardised).

Local cancer incidence rates also available for breast, cervical, prostate, colorectal, lung and melanoma of the skin.